Loading clinical trials...
Loading clinical trials...
The purpose of this study is to determine whether the levonorgestrel-releasing intrauterine system is effective in decreasing menstrual blood loss.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Bayer
NCT05922657 · Heavy Menstrual Bleeding, Abnormal Uterine Bleeding, and more
NCT06538454 · Arterial Hypertension, Postmenopausal; Menorrhagia, and more
NCT03670680 · Menorrhagia
NCT05538689 · Metrorrhagia, Pelvic Pain, and more
NCT07188259 · Menorrhagia
Tucson, Arizona
Beverly Hills, California
Carmichael, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions